))
Dr. Robert Kaufman and the new ValidCare Safety Study on CBD
Manage episode 329557448 series 2965541
Contenido proporcionado por Jonathan Miller and Jonathan Miller - National Leading Hemp Attorney. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Jonathan Miller and Jonathan Miller - National Leading Hemp Attorney o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Hemp Industry Episode Resources:
Host: Jonathan Miller
Guest: Dr. Robert Kaufman
Blog: Hemp Legally Speaking
Hemp Industry questions covered in the episode:
- What does the ValidCare study demonstrate about the safety of ingestible CBD?
- What did the study conclude about CBD’s liver toxicity and how does this contrast with studies done on Epidiolex, the CBD drug used by children with rare forms of epilepsy?
- How does the study address concerns about drowsiness and low testosterone?
- Statistically speaking, how strong are the study’s conclusions
- What’s the message that Dr. Kaufman will be sharing with FDA in its upcoming meeting?
53 episodios
Compartir
